In the BioHarmony Drug Report Database

"Preview" Icon

Botulinum toxin type a

Dysport, Nuceiva (botulinum toxin type a) is an unknown pharmaceutical. Botulinum toxin type a was first approved as Dysport on 2019-09-27. It is used to treat blepharospasm, dystonia, fissure in ano, genetic skin diseases, and muscle rigidity amongst others in the USA. It has been approved in Europe to treat skin aging.

 

Trade Name

 

Nuceiva
 

Common Name

 

botulinum toxin type a
 

ChEMBL ID

 

CHEMBL4297862
 

Indication

 

blepharospasm, dystonia, fissure in ano, genetic skin diseases, muscle rigidity, skin aging, strabismus
 

Drug Class

 

Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)

Image (chem structure or protein)

Botulinum toxin type a structure rendering